CUSIP: 040047102
What is CUSIP 040047102?
CUSIP 040047102 identifies ARNA - ARENA PHARMECEUTICALS INC - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 040047102:
As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1 | $1 | $1.00 | 1 | |
| 2025 Q3 | 1 | $1 | $1.00 | 1 | |
| 2025 Q2 | 1 | $1 | $1.00 | 1 | |
| 2025 Q1 | 1 | $1 | $1.00 | 1 | |
| 2024 Q4 | 1 | $1 | $1.00 | 1 | |
| 2024 Q3 | 1 | $1 | $1.00 | 1 | |
| 2024 Q2 | 1 | $1 | $1.00 | 1 | |
| 2024 Q1 | 1 | $1 | $1.00 | 1 | |
| 2023 Q4 | 1 | $1 | $1.00 | 1 | |
| 2023 Q3 | 1 | $1 | $1.00 | 1 | |
| 2023 Q2 | 1 | $1 | $1.00 | 1 | |
| 2023 Q1 | 1 | $1 | $1.00 | 1 | |
| 2022 Q4 | 1 | $1 | +$1 | $1.00 | 1 |
| 2020 Q3 | 0 | $0 | -$2,000 | $1.00 | 0 |
| 2020 Q2 | 38 | $2,000 | -$288,000 | $52.63 | 1 |
| 2020 Q1 | 7 | $290,000 | +$290,000 | $41428.57 | 1 |
| 2017 Q4 | 0 | $0 | -$433,000 | $1.00 | 0 |
| 2017 Q3 | 17,000 | $433,000 | -$6,737,000 | $25.47 | 1 |
| 2017 Q2 | 425,000 | $7,170,000 | -$221,371,968 | $16.87 | 1 |
| 2017 Q1 | 111,692,100 | $163,070,938 | +$26,152,577 | $1.46 | 123 |
| 2016 Q4 | 112,666,736 | $159,990,947 | -$12,144,275 | $1.42 | 122 |
| 2016 Q3 | 120,921,346 | $211,511,054 | +$3,545,626 | $1.75 | 121 |
| 2016 Q2 | 118,920,888 | $203,340,039 | +$1,888,573 | $1.71 | 114 |
| 2016 Q1 | 116,034,844 | $228,560,096 | -$4,567,078 | $1.97 | 103 |
| 2015 Q4 | 118,484,467 | $225,110,688 | -$40,842,212 | $1.90 | 114 |
| 2015 Q3 | 139,552,520 | $266,569,438 | -$21,293,541 | $1.91 | 114 |
| 2015 Q2 | 139,872,743 | $648,909,816 | +$215,666 | $4.64 | 124 |
| 2015 Q1 | 139,925,414 | $611,668,007 | +$113,211,969 | $4.37 | 120 |
| 2014 Q4 | 114,838,152 | $398,313,272 | +$25,733,428 | $3.47 | 125 |
| 2014 Q3 | 108,086,221 | $452,847,863 | +$11,286,588 | $4.19 | 119 |
| 2014 Q2 | 104,889,098 | $614,619,942 | +$12,601,291 | $5.86 | 125 |
| 2014 Q1 | 102,473,851 | $645,680,160 | -$29,287,003 | $6.30 | 127 |